PIERRE FABRE CDMO

PIERRE FABRE CDMO

About

Company description

The core expertise of Pierre Fabre CDMO is the fill & finish of injectables products, now completed with the manufacturing of clinical batches of biotech molecules (mAbs, ADC). PF-CDMO also proposes the development and commercial production of APIs and nutraceutical ingredients, and oral products, such as liquids, tablets and pharmaceutical lozenges.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: API Contract Manufacturing |Biotechnology and related specialities |Contract Manufacturing More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 121C50 See our Exhibitor Profile   See full Exhibitor List
9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 1D63 See our Exhibitor Profile   See full Exhibitor List
24 apr 2018

CPhI North America 2018

24-26 April, 2018 Philadelphia, USA We were at stand 357 See our Exhibitor Profile   See full Exhibitor List

News about PIERRE FABRE CDMO

New oral treatment for metastatic melanoma receives EU authorisation

24 Sep 2018

New oral treatment for metastatic melanoma receives EU authorisation

Encorafenib in combination with binimetinib demonstrated 14.9 months median progression-free survival compared with vemurafenib monotherapy (7.3 months).

Read more
PIERRE FABRE CDMO

Contact information

Address

Telephone

Website

View all contact information